Stock Research for MYGN


Featured Broker: Ally Invest

Get the due diligence for another stock.


MYGN Stock Chart & Research Data

The MYGN chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the MYGN chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


MYGN Due diligence Resources & Stock Charts

The MYGN stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View MYGN Detailed Price Forecast - CNN Money CNN View MYGN Detailed Summary - Google Finance
Yahoo View MYGN Detailed Summary - Yahoo! Finance Zacks View MYGN Stock Research & Analysis -

Stock Analysis

TradeIdeas View MYGN Trends & Analysis - Trade-Ideas Barrons View MYGN Major Holders - Barrons
NASDAQ View MYGN Call Transcripts - NASDAQ Seeking View MYGN Breaking News & Analysis - Seeking Alpha
Spotlight View MYGN Annual Report - OTC Report View MYGN OTC Short Report -
TradeKing View MYGN Fundamentals - TradeKing Charts View MYGN SEC Filings - Bar Chart
WSJ View Historical Prices for MYGN - The WSJ Morningstar View Performance/Total Return for MYGN - Morningstar
MarketWatch View the Analyst Estimates for MYGN - MarketWatch CNBC View the Earnings History for MYGN - CNBC
StockMarketWatch View the MYGN Earnings - StockMarketWatch MacroAxis View MYGN Buy or Sell Recommendations - MacroAxis
Bullish View the MYGN Bullish Patterns - American Bulls Short Pains View MYGN Short Pain Metrics -

Social Media Mentions

StockTwits View MYGN Stock Mentions - StockTwits PennyStocks View MYGN Stock Mentions - PennyStockTweets
Twitter View MYGN Stock Mentions - Twitter Invest Hub View MYGN Investment Forum News - Investor Hub
Yahoo View MYGN Stock Mentions - Yahoo! Message Board Seeking Alpha View MYGN Stock Mentions - Seeking Alpha

Financial & Transaction Holdings

SECform4 View Insider Transactions for MYGN - Insider Cow View Insider Transactions for MYGN - Insider Cow
CNBC View MYGN Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for MYGN - OTC Markets
Yahoo View Insider Transactions for MYGN - Yahoo! Finance NASDAQ View Institutional Holdings for MYGN - NASDAQ

Stock Charts

FinViz View MYGN Stock Insight & Charts - StockCharts View MYGN Investment Charts -
BarChart View MYGN Stock Overview & Charts - BarChart Trading View View MYGN User Generated Charts - Trading View

Latest Financial News for MYGN

See what the IHS Markit Score report has to say about Myriad Genetics Inc.
Posted on Tuesday January 15, 2019

# Myriad Genetics Inc ### NASDAQ/NGS:MYGN View full report here! ## Summary * Bearish sentiment is moderate ## Bearish sentiment Short interest | Negative Short interest is moderately high for MYGN with between 10 and 15% of shares outstanding currently on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. ## Money flow ETF/Index ownership | Neutral ETF activity is neutral. The net inflows of $2.90 billion over the last one-month into ETFs that hold MYGN are not among the highest of the last year and have been slowing. ## Economic sentiment PMI by IHS Markit | Neutral According to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is strong relative to the trend shown over the past year, but is easing. ## Credit worthiness Credit default swap CDS data is not available for this security. Please send all inquiries related to the report to Charts and report PDFs will only be available for 30 days after publishing. This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.

MYGN vs. SWTUY: Which Stock Should Value Investors Buy Now?
Posted on Friday January 11, 2019

MYGN vs. SWTUY: Which Stock Is the Better Value Option?

Has Myriad Genetics (MYGN) Outpaced Other Medical Stocks This Year?
Posted on Friday January 11, 2019

Is (MYGN) Outperforming Other Medical Stocks This Year?

Epizyme to File NDA for Tazemetostat in Follicular Lymphoma
Posted on Monday January 07, 2019

Epizyme (EPZM) announces that the company has identified a path to submission for accelerated approval of tazemetostat for patients with relapsed and/or refractory follicular lymphoma.

Stock Market & Investing Books

Enter a stock symbol to view the stock details.